Skip to main content Accessibility help
×
Home
Hostname: page-component-7f7b94f6bd-lv2sk Total loading time: 0.277 Render date: 2022-06-30T06:54:15.628Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true } hasContentIssue true

Inulin and oligofructose: impact on intestinal diseases and disorders

Published online by Cambridge University Press:  08 March 2007

Francisco Guarner*
Affiliation:
Digestive System Research Unit, University Hospital Vall d'Hebron, Passeig Vall d'Hebron 119–129, Barcelona, 08035, Spain
*
*Corresponding author:, Dr Francisco Guarner, fax +34 934894456, email fguarnera@medynet.com
Rights & Permissions[Opens in a new window]

Abstract

HTML view is not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A large and diverse variety of bacteria have evolved and adapted to live in the human intestinal habitat in a symbiotic arrangement that influences both physiology and pathology in the host. Symbiosis between host and flora can be optimised by prebiotics. Inulin-type fructans have been shown to improve the metabolic functions of the commensal flora. Clinical and experimental data suggest that they also improve the gut mucosal barrier. Furthermore, modulation of the trophic functions of the flora by these prebiotics could help in the prevention of inflammatory bowel diseases. The anti-inflammatory effects of inulin or oligofructose have been assessed in the rat model of distal colitis induced by dextran sodium sulphate, which histologically resembles human ulcerative colitis, and in the trinitrobenzene sulphonic acid model that resembles human Crohn's disease. Both inulin and oligofructose stimulate colonic production of SCFA and favour the growth of indigenous lactobacilli and/or bifidobacteria. These effects are associated with reduced mucosal inflammation and decreased mucosal lesion scores. Inulin has also been tested in a placebo-controlled clinical trial in patients with relapsing pouchitis. Treatment reduced endoscopic and histological parameters of inflammation of the pouch mucosa. Inulin and oligofructose may offer an opportunity to prevent chronic inflammatory intestinal disorders, and this potential should be tested in further clinical studies.

Type
Research Article
Copyright
Copyright © The Nutrition Society 2005

References

Aderem, A & Ulevitch, RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406, 782787.CrossRefGoogle ScholarPubMed
Appleyard, CB & Wallace, JL (1995) Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 269, G119G125.Google ScholarPubMed
Bach, JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347, 911920.CrossRefGoogle ScholarPubMed
Borruel, N, Carol, M, Casellas, F, Antolín, M, de Lara, F, Espín, E, Naval, J, Guarner, F & Malagelada, JR (2002) Increased mucosal TNFα production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 51, 659664.CrossRefGoogle ScholarPubMed
Borruel, N, Casellas, F, Antolín, M, Carol, M, Llopis, M, Espín, E, Naval, J, Guarner, F & Malagelada, JR (2003) Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am J Gastroenterol 98, 865870.CrossRefGoogle ScholarPubMed
Bourlioux, P, Braesco, V, Koletzko, B & Guarner, F (2003) The intestine and its microflora are partners for the protection of the host. Am J Clin Nutr 78, 675683.CrossRefGoogle Scholar
Carol, M, Borruel, N, Antolín, M, Casellas, F, Guarner, F, Malagelada, J-R (2003) Lactobacillus casei can overcome resistance to apoptosis in lymphocytes from patients with Crohn's disease. Gastroenterology 124 A321CrossRefGoogle Scholar
Casellas, F, Borruel, N, Papo, M, Guarner, F, Antolín, M, Videla, S & Malagelada, JR (1998) Antiinflammatory effects of enterically coated amoxicillin–clavulanic acid in active ulcerative colitis. Inflamm Bowel Dis 4, 15.CrossRefGoogle ScholarPubMed
Cherbut, C, Michel, C & Lecannu, G (2003) The prebiotic characteristics of fructooligo-saccharides are necessary for reduction of TNBS-induced colitis in rats. J Nutr 133, 2127.CrossRefGoogle Scholar
Cooper, HS, Murthy, SN, Shah, RS & Sedergran, DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69, 238249.Google ScholarPubMed
Cummings, JH, Christie, S & Cole, TJ (2001) A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Aliment Pharmacol Ther 15, 11391145.CrossRefGoogle ScholarPubMed
D'Haens, GR, Geboes, K, Peeters, M, Baert, F, Penninckx, F & Rutgeerts, P (1998) Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114, 262267.CrossRefGoogle ScholarPubMed
Delzenne, NM, Daubioul, C, Neyrinck, A, Lasa, M & Taper, HS (2002) Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects. Br J Nutr 87, Suppl. 2, S255S259.CrossRefGoogle ScholarPubMed
Fagarasan, S, Muramatsu, M, Suzuki, K, Nagaoka, H, Hiai, H & Honjo, T (2002) Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298, 14141427.CrossRefGoogle ScholarPubMed
Femia, AP, Luceri, C, Dolara, P, Giannini, A, Biggeri, A, Salvadori, M, Clune, Y, Collins, KJ, Paglierani, M & Caderni, G (2002) Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23, 19531960.CrossRefGoogle ScholarPubMed
Gibson, GR & Roberfroid, MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 14011412.Google ScholarPubMed
Griffin, IJ, Davila, PM & Abrams, SA (2002) Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. Br J Nutr 87 Suppl. 2 S187S191.CrossRefGoogle ScholarPubMed
Guarner, F (2003) Microecology as a target for therapeutic intervention in inflammatory bowel disease. IDrugs 6, 868873.Google ScholarPubMed
Guarner, F & Malagelada, JR (2003) Gut flora in health and disease. Lancet 361, 512519.CrossRefGoogle ScholarPubMed
Hooper, LV, Wong, MH, Thelin, A, Hansson, L, Falk, PG & Gordon, JI (2001) Molecular analysis of commensal host–microbial relationships in the intestine. Science 291, 881884.CrossRefGoogle ScholarPubMed
Kagnoff, MF & Eckmann, L (1997) Epithelial cells as sensors for microbial infection. J Clin Invest 100, 610.CrossRefGoogle ScholarPubMed
Kennedy, RJ, Hoper, M, Deodhar, K, Kirk, SJ & Gardiner, KR (2000) Probiotic therapy fails to improve gut permeability in a hapten model of colitis. Scand J Gastroenterol 35, 12661271.Google Scholar
McCarthy, J, O'Mahony, L, O'Callaghan, L (2003) Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52, 975980.CrossRefGoogle ScholarPubMed
Macpherson, A, Khoo, UY, Forgacs, I, Philpott-Howard, J & Bjarnason, I (1996) Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38, 365375.CrossRefGoogle ScholarPubMed
Madsen, KL, Doyle, JS, Jewell, LD, Tavernini, MM & Fedorak, RN (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 11071114.CrossRefGoogle ScholarPubMed
Moreau, NM, Martin, LJ, Toquet, CS, Laboisse, CL, Nguyen, PG, Siliart, BS, Dumon, HJ & Champ, MM (2003) Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in dextran sulfate sodium-induced experimental colitis. Br J Nutr 90, 7585.CrossRefGoogle Scholar
Morris, GP, Beck, PL, Herridge, MS, Depew, WT, Szewezuk, MR & Wallace, JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96, 795803.CrossRefGoogle ScholarPubMed
Nyman, M (2002) Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose. Br J Nutr 87, Suppl. 2S163S168.CrossRefGoogle ScholarPubMed
Olah, A, Belagyi, T, Issekutz, A, Gamal, ME & Bengmark, S (2002) Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 89, 11031107.CrossRefGoogle ScholarPubMed
Pirzer, U, Schönhaar, A, Fleischer, B, Hermann, E, Meyer, zum, Büschenfelde, KH (1991) Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet 338, 12381239.CrossRefGoogle ScholarPubMed
Rayes, N, Seehofer, D, Hansen, S, Boucsein, K, Muller, AR, Serke, S, Bengmark, S & Neuhaus, P (2002) Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74, 123127.CrossRefGoogle ScholarPubMed
Rook, GA & Brunet, LR (2002) Give us this day our daily germs. Biologist (London) 49, 145149.Google ScholarPubMed
Saavedra, JM & Tschernia, A (2002) Human studies with probiotics and prebiotics: clinical implications. Br J Nutr 87, Suppl. 2S241S246.CrossRefGoogle ScholarPubMed
Seksik, P, Rigottier-Gois, L, Gramet, G, Sutren, M, Pochart, P, Marteau, P, Jian, R, Doré, J (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52, 237242.CrossRefGoogle ScholarPubMed
Shanahan, F (2001) Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 120, 622635.CrossRefGoogle ScholarPubMed
Steidler, L, Hans, W, Schotte, L, Neirynck, S, Obermeier, F, Falk, W, Fiers, W & Remaut, E (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289, 13521355.CrossRefGoogle ScholarPubMed
Swidsinski, A, Ladhoff, A & Pernthaler, A (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122, 4454.CrossRefGoogle ScholarPubMed
Van Loo, J, Gibson, GR, Probert, HM, Van Loo, J, Rastall, RA & Roberfroid, MB (1994) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17, 259275.Google Scholar
Videla, S, Vilaseca, J, Antolín, M, García-Lafuente, A, Guarner, F, Crespo, E, Casalots, J, Salas, A & Malagelada, JR (2001) Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am J Gastroenterol 96, 14861493.CrossRefGoogle ScholarPubMed
Welters, CF, Heineman, E, Thunnissen, FB, van den, Bogaard AE, Soeters, PB, Baeten, CG (2002) Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch–anal anastomosis. Dis Colon Rectum 45, 621627.CrossRefGoogle ScholarPubMed
You have Access
56
Cited by

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Inulin and oligofructose: impact on intestinal diseases and disorders
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

Inulin and oligofructose: impact on intestinal diseases and disorders
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

Inulin and oligofructose: impact on intestinal diseases and disorders
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *